Bypassing agent regimens and costs for prophylaxis in patients with inhibitors

被引：0
|
作者：
Gringeri, A. [1 ,2 ]
机构：
[1] IRCCS Maggiore Policlin, Dept Med & Med Special, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, Regina Elena Hosp Fdn, I-20122 Milan, Italy
[2] Univ Milan, Milan, Italy
来源：
HAEMOPHILIA | 2009年 / 15卷 / 06期
关键词：
HEMOPHILIA-A;
D O I：
10.1111/j.1365-2516.2009.02068.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1336 / 1337
页数：2
相关论文
共 50 条
  • [1] Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors
    Ewenstein, B. M.
    Wong, W. -Y.
    Schoppmann, A.
    HAEMOPHILIA, 2010, 16 (01) : 179 - 180
  • [2] Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors
    Chai-Adisaksopha, Chatree
    Nevitt, Sarah J.
    Simpson, Mindy L.
    Janbain, Maissaa
    Konkle, Barbara A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [3] The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report
    Valentino, L. A.
    Carcao, M.
    Mathew, P.
    Leissinger, C. A.
    Berntorp, E.
    Blanchette, V.
    Escuriola-Ettingshausen, C.
    Ewenstein, B.
    Ewing, N.
    Gringeri, A.
    Hoots, W. K.
    Negrier, C.
    HAEMOPHILIA, 2009, 15 (04) : 959 - 965
  • [4] A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients
    Teitel, J.
    Berntorp, E.
    Dolan, G.
    Fischer, K.
    Gringeri, A.
    Kessler, C.
    Lambert, T.
    Leissinger, C.
    Nemes, L.
    Shima, M.
    HAEMOPHILIA, 2011, 17 (03) : 516 - 521
  • [5] Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors
    Fernanda Lopez-Fernandez, Maria
    Altisent Roca, Carmen
    Teresa Alvarez-Roman, Maria
    Canaro Hirnyk, Mariana Isabel
    Eva Mingot-Castellanos, Maria
    Jimenez-Yuste, Victor
    Cid Haro, Ana Rosa
    Perez-Garrido, Rosario
    Sedano Balbas, Carmen
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (05) : 872 - 895
  • [6] How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors
    Leissinger, Cindy A.
    Singleton, Tammuella
    Kruse-Jarres, Rebecca
    BLOOD, 2015, 126 (02) : 153 - 159
  • [7] Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography
    Young, G.
    Blain, R.
    Nakagawa, P.
    Nugent, D. J.
    HAEMOPHILIA, 2006, 12 (06) : 598 - 604
  • [8] Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors
    Eva Mingot-Castellano, Maria
    Teresa Alvarez-Roman, Maria
    Fernanda Lopez-Fernandez, Maria
    Altisent-Roca, Carmen
    Isabel Canaro-Hirnyk, Mariana
    Jimenez-Yuste, Victor
    Rosa Cid-Haro, Ana
    Perez-Garrido, Rosario
    Sedano-Balbas, Carmen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (05) : 461 - 474
  • [9] BYPASSING AGENTS PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS UNDERGOING SURGERY: A DECISION ANALYSIS IN SPAIN
    Mareque, M.
    Mingot, M. E.
    Lopez, M. F.
    Alvarez, M. T.
    Garcia, J. P.
    Oyaguez, I
    VALUE IN HEALTH, 2017, 20 (09) : A550 - A551
  • [10] Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
    Mareque, Maria
    Mingot-Castellano, Maria Eva
    Lopez-Fernandez, Maria Fernanda
    alvarez-Roman, Maria Teresa
    Oyaguez, Itziar
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (01) : 94 - 100
12345